Zobrazeno 1 - 10
of 629
pro vyhledávání: '"Lasalle M"'
Autor:
Petersen ME; ADC Therapeutic Development, Zymeworks Inc., Vancouver, British Columbia, Canada., Brant MG; ADC Therapeutic Development, Zymeworks Inc., Vancouver, British Columbia, Canada., Lasalle M; ADC Therapeutic Development, Zymeworks Inc., Vancouver, British Columbia, Canada., Das S; ADC Therapeutic Development, Zymeworks Inc., Vancouver, British Columbia, Canada., Duan R; ADC Therapeutic Development, Zymeworks Inc., Vancouver, British Columbia, Canada., Wong J; ADC Therapeutic Development, Zymeworks Inc., Vancouver, British Columbia, Canada., Ding T; ADC Therapeutic Development, Zymeworks Inc., Vancouver, British Columbia, Canada., Wu KJ; ADC Therapeutic Development, Zymeworks Inc., Vancouver, British Columbia, Canada., Siddappa D; ADC Therapeutic Development, Zymeworks Inc., Vancouver, British Columbia, Canada., Fang C; ADC Therapeutic Development, Zymeworks Inc., Vancouver, British Columbia, Canada., Zhang W; ADC Therapeutic Development, Zymeworks Inc., Vancouver, British Columbia, Canada., Wu AML; ADC Therapeutic Development, Zymeworks Inc., Vancouver, British Columbia, Canada., Hirkala-Schaefer T; ADC Therapeutic Development, Zymeworks Inc., Vancouver, British Columbia, Canada., Garnett GAE; ADC Therapeutic Development, Zymeworks Inc., Vancouver, British Columbia, Canada., Fung V; ADC Therapeutic Development, Zymeworks Inc., Vancouver, British Columbia, Canada., Yang L; ADC Therapeutic Development, Zymeworks Inc., Vancouver, British Columbia, Canada., Hernandez Rojas A; ADC Therapeutic Development, Zymeworks Inc., Vancouver, British Columbia, Canada., Lawn SO; ADC Therapeutic Development, Zymeworks Inc., Vancouver, British Columbia, Canada., Barnscher SD; ADC Therapeutic Development, Zymeworks Inc., Vancouver, British Columbia, Canada., Rich JR; ADC Therapeutic Development, Zymeworks Inc., Vancouver, British Columbia, Canada., Colombo R; ADC Therapeutic Development, Zymeworks Inc., Vancouver, British Columbia, Canada.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2024 May 02; Vol. 23 (5), pp. 606-618.
Autor:
Levtchenko, E., Haffner, D., Bjerre, A., Massy, Z., Shtiza, D., Kramar, R., Oberbauer, R., Baiko, S., Sukalo, A., van Hoeck, K., Collart, F., des Grottes, J.M., Pokrajac, D., Roussinov, D., Batinić, D., Lemac, M., Slavicek, J., Seeman, T., Vondrak, K., Heaf, J.G., Toots, U., Finne, P., Grönhagen-Riska, C., Couchoud, C., Lasalle, M, Sahpazova, E, Abazi, N, Ristoka Bojkovska, N, von Gersdorff, G, Scholz, C, Tönshoff, B, Krupka, K, Höcker, B, Pape, L, Afentakis, N, Kapogiannis, A, Printza, N, Reusz, G, Berecki, Cs, Szabó, A, Szabó, T, Györke, Z.S., Kis, E., Palsson, R., Edvardsson, V., Gianoglio, B., Maringhini, S., Pecoraro, C., Picca, S., Testa, S., Vidal, E., Verrina, E., Jankauskiene, A., Pundziene, B., Said-Conti, V., Gatcan, S., Berbeca, O., Zaikova, N., Pavićević, S., Leivestad, T., Zurowska, A., Zagozdzon, I., Mota, C., Almeida, M., Afonso, C., Mircescu, G., Garneata, L., Molchanova, E.A., Tomilina, N.A., Bikbov, B.T., Kostic, M., Peco-Antic, A., Spasojevic-Dimitrijeva, B., Milosevski-Lomic, G., Paripovic, D., Puric, S., Kruscic, D., Podracka, L., Kolvek, G., Buturovic-Ponikvar, J., Novljan, G., Battelino, N., Alonso Melgar, A., Schön, S., Prütz, K.G., Backmän, L., Stendahl, M., Evans, M., Rippe, B., Kuenhi, C.E., Maurer, E., Laube, G.F., Tschumi, S., Parvex, P., Hoitsma, A., Hemke, A., Topaloglu, R., Duzova, A., Ivanov, D., Pruthi, R., Braddon, F., Mannings, S., Cassula, A., Sinha, M.D., Mekahli, Djalila, van Stralen, Karlijn J., Bonthuis, Marjolein, Jager, Kitty J., Balat, Ayşe, Benetti, Elisa, Godefroid, Nathalie, Edvardsson, Vidar O., Heaf, James G., Jankauskiene, Augustina, Kerecuk, Larissa, Marinova, Svetlana, Puteo, Flora, Seeman, Tomas, Zurowska, Aleksandra, Pirenne, Jacques, Schaefer, Franz, Groothoff, Jaap W.
Publikováno v:
In American Journal of Kidney Diseases November 2016 68(5):782-788
Autor:
Picon S; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177─Drugs and Molecules for Living Systems, F-59000 Lille, France., Boulahjar R; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177─Drugs and Molecules for Living Systems, F-59000 Lille, France., Hoguet V; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177─Drugs and Molecules for Living Systems, F-59000 Lille, France., Baron M; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France., Duplan I; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France., Vallez E; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France., Hennuyer N; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France., Dumont J; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177─Drugs and Molecules for Living Systems, F-59000 Lille, France.; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41─UAR 2014─PLBS, F-59000 Lille, France., Touche V; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France., Dorchies E; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France., Lasalle M; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177─Drugs and Molecules for Living Systems, F-59000 Lille, France., Descat A; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177─Drugs and Molecules for Living Systems, F-59000 Lille, France., Piveteau C; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177─Drugs and Molecules for Living Systems, F-59000 Lille, France., Biela A; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177─Drugs and Molecules for Living Systems, F-59000 Lille, France., Chaput L; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177─Drugs and Molecules for Living Systems, F-59000 Lille, France., Villoutreix BO; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177─Drugs and Molecules for Living Systems, F-59000 Lille, France., Lipka E; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167─RID-AGE─Facteurs de risque et déterminants moléculaires des maladies liées au vieillissement, F-59000 Lille, France., Sevin E; Univ. Artois, UR 2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), F-62300 Lens, France., Culot M; Univ. Artois, UR 2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), F-62300 Lens, France., Gosselet F; Univ. Artois, UR 2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), F-62300 Lens, France., Lestavel S; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France., Roussel P; Univ. Lille, CNRS, Centrale Lille, Univ. Artois, UMR 8181─UCCS─Unité de Catalyse et Chimie du Solide, F-59000 Lille, France., Deprez-Poulain R; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177─Drugs and Molecules for Living Systems, EGID, F-59000 Lille, France., Leroux F; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177─Drugs and Molecules for Living Systems, EGID, F-59000 Lille, France.; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41─UAR 2014─PLBS, F-59000 Lille, France., Staels B; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France., Deprez B; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177─Drugs and Molecules for Living Systems, EGID, F-59000 Lille, France.; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41─UAR 2014─PLBS, F-59000 Lille, France., Tailleux A; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France., Charton J; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177─Drugs and Molecules for Living Systems, EGID, F-59000 Lille, France.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2023 Sep 14; Vol. 66 (17), pp. 11732-11760. Date of Electronic Publication: 2023 Aug 28.
Autor:
Brant MG; ADC Therapeutic Development, Zymeworks Inc., Vancouver, BC, Canada. Electronic address: michael.brant@zymeworks.com., Garnett GAE; ADC Therapeutic Development, Zymeworks Inc., Vancouver, BC, Canada., Guedia J; ADC Therapeutic Development, Zymeworks Inc., Vancouver, BC, Canada., Lasalle M; ADC Therapeutic Development, Zymeworks Inc., Vancouver, BC, Canada., Lawn S; ADC Therapeutic Development, Zymeworks Inc., Vancouver, BC, Canada., Petersen ME; ADC Therapeutic Development, Zymeworks Inc., Vancouver, BC, Canada., Duan R; ADC Therapeutic Development, Zymeworks Inc., Vancouver, BC, Canada., Mendez-Campos J; ADC Therapeutic Development, Zymeworks Inc., Vancouver, BC, Canada., Hirkala-Schaefer T; ADC Therapeutic Development, Zymeworks Inc., Vancouver, BC, Canada., Winters GC; ADC Therapeutic Development, Zymeworks Inc., Vancouver, BC, Canada., Barnscher SD; ADC Therapeutic Development, Zymeworks Inc., Vancouver, BC, Canada. Electronic address: stuart.barnscher@zymeworks.com.
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2023 Jul 15; Vol. 91, pp. 129348. Date of Electronic Publication: 2023 May 20.
Autor:
Petersen ME; ADC Therapeutic Development, Zymeworks Inc., Vancouver, BC V5T 1G4, Canada., Brant MG; ADC Therapeutic Development, Zymeworks Inc., Vancouver, BC V5T 1G4, Canada., Lasalle M; ADC Therapeutic Development, Zymeworks Inc., Vancouver, BC V5T 1G4, Canada., Fung VKC; ADC Therapeutic Development, Zymeworks Inc., Vancouver, BC V5T 1G4, Canada., Rojas AH; ADC Therapeutic Development, Zymeworks Inc., Vancouver, BC V5T 1G4, Canada., Wong J; ADC Therapeutic Development, Zymeworks Inc., Vancouver, BC V5T 1G4, Canada., Das S; ADC Therapeutic Development, Zymeworks Inc., Vancouver, BC V5T 1G4, Canada., Barnscher SD; ADC Therapeutic Development, Zymeworks Inc., Vancouver, BC V5T 1G4, Canada., Rich JR; ADC Therapeutic Development, Zymeworks Inc., Vancouver, BC V5T 1G4, Canada., Winters GC; Technical and Manufacturing Operations, Zymeworks Inc., Vancouver, BC V5T 1G4, Canada.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2023 Jun 22; Vol. 66 (12), pp. 8288-8309. Date of Electronic Publication: 2023 Jun 12.
Autor:
Lasalle M; Department of Psychology, University of Quebec in Montreal, Montreal, QC, Canada., Hess U; Department of Psychology, University of Quebec in Montreal, Montreal, QC, Canada.; Department of Psychology, Humboldt University, Berlin, Germany.
Publikováno v:
Frontiers in psychology [Front Psychol] 2022 Nov 10; Vol. 13, pp. 1022462. Date of Electronic Publication: 2022 Nov 10 (Print Publication: 2022).
Perfectionism and Adolescent Athletes' Burnout: The Serial Mediation of Motivation and Coping Style.
Autor:
Xu, Aiai1 (AUTHOR) xaa@mails.ccnu.edu.cn, Luo, Xiaobing1 (AUTHOR) lxbccnu@126.com, Qiu, Xueqing1,2 (AUTHOR) qiuxq1229@163.com, Lu, Changfen1 (AUTHOR) lcfccnu@126.com
Publikováno v:
Behavioral Sciences (2076-328X). Nov2024, Vol. 14 Issue 11, p1011. 13p.
Autor:
Hoguet V; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, F-59000 Lille, France., Lasalle M; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, F-59000 Lille, France., Maingot M; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, F-59000 Lille, France., Dequirez G; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, F-59000 Lille, France., Boulahjar R; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, F-59000 Lille, France., Leroux F; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, EGID, F-59000 Lille, France., Piveteau C; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, F-59000 Lille, France., Herledan A; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, F-59000 Lille, France., Biela A; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, F-59000 Lille, France., Dumont J; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, F-59000 Lille, France., Chávez-Talavera O; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France., Belloy L; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France., Duplan I; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France., Hennuyer N; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France., Butruille L; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France., Lestavel S; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France., Sevin E; Univ. Artois, UR 2465, Blood-brain barrier laboratory (LBHE), F-62300 Lens, France., Culot M; Univ. Artois, UR 2465, Blood-brain barrier laboratory (LBHE), F-62300 Lens, France., Gosselet F; Univ. Artois, UR 2465, Blood-brain barrier laboratory (LBHE), F-62300 Lens, France., Staels B; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France., Deprez B; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, EGID, F-59000 Lille, France., Tailleux A; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France., Charton J; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, EGID, F-59000 Lille, France.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2021 Feb 11; Vol. 64 (3), pp. 1593-1610. Date of Electronic Publication: 2021 Jan 20.
Autor:
Morrey, Douglas1 (AUTHOR) D.J.Morrey@warwick.ac.uk
Publikováno v:
French Screen Studies. Jul2024, p1-19. 19p. 4 Illustrations.
Autor:
Sabra, Ayman1 (AUTHOR) ayman.sabra@pfizer.com, Bourgeois, Marie2 (AUTHOR) ayman.sabra@pfizer.com, Blanc, Emmanuelle2 (AUTHOR), Fievez, Stephane3 (AUTHOR), Moïsi, Jennifer1 (AUTHOR), Goussiaume, Gwenaël2 (AUTHOR), Lemaitre, Magali4 (AUTHOR), Watier, Laurence5 (AUTHOR), Coulombel, Nicolas4 (AUTHOR), Tréhony, Julien4 (AUTHOR), Tricotel, Aurore4 (AUTHOR), Baghdadi, Yasmine4 (AUTHOR), Fartoukh, Muriel S6 (AUTHOR)
Publikováno v:
Open Forum Infectious Diseases. Jul2024, Vol. 11 Issue 7, p1-9. 9p.